Abstract: The present invention relates to a method of post-treating a zeolite membrane, comprising treating a defective zeolite membrane with a chemical material such as a dye molecule, which has a size larger than that of the pores of the zeolite membranes and smaller than defects in the membrane, thereby healing the defects in the membrane. The post-treatment method performs post-treatment of the zeolite membrane under mild conditions (room temperature and normal pressure), thereby selectively healing the defects in the zeolite membrane and improving the performance of the zeolite membrane. In addition, the method may provide a high-performance membrane having a high separation factor, particularly under dry conditions.

Abstract: An object of the present invention is to provide an oxaliplatin-encapsulating liposome aqueous dispersion that has excellent long-term storage stability. The present invention provides an aqueous dispersion of liposomes encapsulating oxaliplatin, the oxaliplatin-encapsulating liposome aqueous dispersion containing 2-morpholinoethanesulfonic acid in an external aqueous phase.

Abstract: Provided is a hydrogen generating apparatus adaptable to fluctuating hydrogen demand, particularly by enabling large-scale hydrogen production, generating pure hydrogen at a high yield. The hydrogen generating apparatus 1 generates hydrogen gas from a source gas by decomposing the source gas through catalysis and transforming it into plasma through electric discharge. The hydrogen generating apparatus 1 includes a dielectric body 2 defining a source gas flow channel 13, a catalyst 10 that decomposes at least part of the source gas in the source gas flow channel 13 to generate hydrogen gas, an electrode 3 contacting the dielectric body 2, a hydrogen separation membrane 5 facing the electrode 3 across the dielectric body 2, a hydrogen flow channel 18 guiding hydrogen separated by the hydrogen separation membrane 5, and a high-voltage power supply 6 supplying power to cause electric discharge between the hydrogen separation membrane 5 and the electrode 3.

Abstract: Disclosed is a composite membrane comprising a mixed matrix membrane comprising a polymer matrix and fillers dispersed in the polymer matrix. The polymer matrix comprises a polymer having a polar functional group. The H2 permeability coefficient of the polymer matrix is 20 Barrer or more at 4 bar and 298 K. The filler has a polar functional group that may be capable of forming a hydrogen bond with the polar functional group of the polymer, and has an average diameter of 100 nm or less.

Abstract: A method for the preparation of zirconia-multi-walled carbon nanotube nanocomposite utilizing Pluronics as templating agents is described. An efficient method for producing hydrogen gas using the nanocomposite as a photocatalyst.

Abstract: The present invention discloses POSS-based non-isocyanate polyurethane modified poly(propylene carbonate), comprising poly(propylene carbonate) and 1 to 20 wt % of POSS-based non-isocyanate polyurethane. The POSS-based non-isocyanate polyurethane has a structure shown by the formula (I) or the formula (II). Under the action of a catalyst, POSS-based epoxy compound is subjected to cycloaddition reaction with CO2 to obtain POSS-based cyclic carbonate, and then the POSS-based cyclic carbonate is subjected to ring-opening reaction with monoamino compound to prepare the POSS-based non-isocyanate polyurethane. POSS has both the flexibility of organic silicon materials and the strength of inorganic silicon materials to enhance the toughening and strengthening of of poly(propylene carbonate).

Abstract: A nanocrystal with a large Stokes shift includes a matrix domain having a composition of M1xM2yAz, and a plurality of seed domains which are distributed in the matrix domain and each of which has a composition of M1x?M2y?Az?, wherein M1, M2, A, x, y, z, x?, y?, and z? are as defined herein.

Abstract: Provided is a method for producing a polyisoprenoid, which can increase natural rubber production by enhancing the rubber synthesis activity of rubber particles. The present invention provides methods for producing a polyisoprenoid using a gene coding for a cis-prenyltransferase (CPT) family protein, a gene coding for a Nogo-B receptor (NgBR) family protein and a gene coding for a rubber elongation factor (REF) family protein, specifically a method for producing a polyisoprenoid in vitro using rubber particles bound to proteins coded for by these genes, and a method for producing a polyisoprenoid in vivo using a recombinant organism (plant) having these genes introduced therein.

Abstract: A system and method of automatically assessing pediatric and neonatal pain using facial expressions along with crying sounds, body movement, and vital signs change to improve the diagnosis and treatment of pain in the pediatric patient population.

Abstract: A state prediction apparatus includes an information processing device. The information processing device is configured to acquire first input data related to at least one of biological information and action information of a user. The information processing device is configured to execute a prediction operation to predict a status of the user based on the first input data. The information processing device is configured to repeat a learning process for optimizing details of the prediction operation by using a first data portion and second data portion of second input data. The second input data is related to at least one of the biological information and action information of the user. The second input data is not associated with correct data indicating the status of the user. The second data portion is different from the first data portion.

Abstract: The present invention relates to u disorder of the lower urinary tract, and in particular, reducing the symptoms (including treatment) of interstitial cystitis in vivo. In a preferred embodiment, the present invention relates to treatment formulations and methods for reducing interstitial cystitis in patients.

Abstract: The present invention relates to tolerogenic mammalian dendritic cells (iDCs) and methods for the production of tolerogenic DCs. In addition, the present invention provides methods for administration of tolerogenic dendritic cells as well as particles containing oligonucleotides to mammalian subjects. Enhanced tolerogenicity in a host can be useful for treating inflammatory and autoimmune related diseases, such as type 1 diabetes.

Abstract: A genetically-modified, immunodeficient mouse is provided along with methods of use, wherein the mouse includes (a) a nucleotide sequence encoding human stem cell factor (hSCF); (b) a nucleotide sequence encoding human granulocyte-macrophage colony-stimulating factor (hGM-CSF); (c) a nucleotide sequence encoding human interleukin-3 (hIL-3); and (d) a nucleotide sequence encoding human colony-stimulating factor 1 (hCSF1), wherein each of the nucleotide sequences is operably linked to a promoter, and wherein the genetically-modified, immunodeficient mouse expresses hSCF, hGM-CSF, hIL-3, and hCSF1, wherein the genetically-modified, immunodeficient mouse allows engraftment of human hematopoietic stem cells along with engraftment of human-patient derived tumor xenografts and/or human tumor cell lines to enable in vivo investigation of the interactions between the human immune system and human cancer.

Abstract: Novel organometallic complexes having a structure of Formula (I) that are useful in organic light emitting devices are disclosed.

Abstract: This invention relates to a microelectromechanical device for mechanical characterization of a specimen. In one embodiment the device may incorporate a substrate, at least one first flexure bearing and at least one second flexure bearing, both being supported on the substrate. First and second movable shuttles may be used which are supported above the substrate by the flexure bearings so that each is free to move linearly relative to the substrate. Ends of the movable shuttles are separated by a gap. A thermal actuator may be connected to one end of the first movable shuttle, and operates to cause the first movable shuttle to move in a direction parallel to the surface of the substrate in response to a signal applied to the thermal actuator. A first capacitive sensor may be formed between the first movable shuttle and the substrate, and a second capacitive sensor formed between the second movable shuttle and the substrate.

Abstract: Embodiments herein report compositions of alpha-1 antitrypsin fusion polypeptides or peptide derivatives thereof. In certain embodiments, compositions and methods relate to generating a construct of use in pharmaceutically acceptable compositions to treat a subject in need of alpha-1 antitrypsin therapy or treatment. In other embodiments, compositions and methods disclosed herein concern linking alpha-1 antitrypsin or derivative thereof to an immune fragment.

Abstract: Embodiments of the present invention relate to methods of preparing a cell, tissue, organ or plant for cryopreservation, wherein the method includes contacting the cell, tissue, organ or plant with a composition including sucrose and/or sucralose.

Abstract: An embodiment includes an optical transmission module, an optical transceiver, and an optical communication system including the same, the optical transmission module comprising: a light emitting diode; and an optical modulator for modulating first light emitted from the light emitting diode, wherein the light emitting diode and the optical modulator include GaN, and the optical modulator transmits the first light therethrough when a voltage is applied.

Abstract: Disclosed herein are systems and methods for specifying treatment criteria and treatment planning parameters for patient specific radiation therapy planning. According to an aspect, a method includes receiving data about a patient, computing geometric characterization of one or more organs at risk proximate to a target volume of a patient or vice versa, and selecting relevant treatment knowledge and experience. The method also includes generating, based on the received data, computed geometric characterization, and available knowledge and experience, a first set of radiation treatment planning parameters that will lead to a high quality plan for the patient. Further, the method includes model-based prediction, based on the data, a second set or more of radiation treatment planning parameters that will lead to alternative achievable plans with different organ sparing objectives for treating the patient. The multiple sets for parameters can be used separately or in conjunction to generate treatment plans.

Abstract: A method for task scheduling on a heterogeneous multi-core reconfigurable computing platform is disclosed, the method includes: determining an execution manner of a target task according to popularity of the to-be-executed target task and usage of a reconfigurable resource of the heterogeneous multi-core reconfigurable computing platform, where the execution manner includes a hardware manner or a software manner, for the target task, there is no corresponding target intellectual property IP core for executing the target task on the heterogeneous multi-core reconfigurable computing platform, the popularity of the target task is used to indicate central processing unit CPU usage of the target task, and the usage of the reconfigurable resource is used to indicate a usage status of the reconfigurable resource; and executing the target task according to the determined execution manner.